Form S-1
Please note that where we provide examples or references to portions of your filing to illustrate what we mean by our comments, they are examples and not exhaustive lists. If our comments are applicable to portions of the filings that we have not cited as examples, please make the appropriate changes elsewhere in the filing in accordance with our comments.
The Company confirms its understanding of the Staff's comment and has made appropriate changes throughout Amendment No. 1.Read in the reply
Please submit all exhibits as soon as practicable. We may have further comments upon examination of these exhibits.
The Company confirms its understanding of the Staff's comment and has submitted additional exhibits for the Staff's review with Amendment No. 1.Read in the reply
Please supplementally provide us with copies of all written communications, as defined in Rule 405 under the Securities Act, that you, or anyone authorized to do so on your behalf, present to potential investors in reliance on Section 5(d) of the Securities Act, whether or not they retain copies of the communications.Rest of the question
Similarly, please supplementally provide us with any research reports about you that are published or distributed in reliance upon Section 2(a)(3) of the Securities Act of 1933 added by Section 105(a) of the Jumpstart Our Business Startups Act by any broker or dealer that is participating or will participate in your offering.
The Company respectfully submits to the Staff that it is not aware of any written communications or research reports that are responsive to Comment 3. As the Registration Statement is a resale registration statement, it is not known what, if any, shares of the Company's common stock will be offered or sold pursuant to the Registration Statement or which broker-dealers will participate in the offering. The holders of the registered shares will make decisions as to what shares will be offered and what broker-dealers will participate in any offerings made pursuant to the Registration Statement.Read in the replyRest of the answer
As described below, FBR Capital Markets & Co. (“FBRC”) acted as the initial purchaser and placement agent in the Company's exempt placement of common stock in April of 2012 (the “Private Offering”). Given its role in the Private Offering, it is likely that FBRC will be a broker-dealer that participates in one or more offerings under the registration statement. At this time, however, neither the Company nor any holder of the Company's common stock has instructed FBRC to act for it in connection with any such offering.
The Company advises the Staff that commencing on May 24, 2012 and continuing until May 20, 2013, FBRC distributed certain private research reports (the “Communications”) to “qualified institutional buyers” (as defined in Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”)) (“QIBs”) and also to “accredited investors” (as defined in Rule 501 under the Securities Act) who purchased shares in the Private Offering. For the reasons discussed below, the Company respectfully submits to the Staff that it does not believe that these communications are of the types requested by Comment 3.
As part of its investment banking business, FBRC regularly acts as placement agent and initial purchaser for equity offerings to its buy-side accounts in transactions exempt from registration under the Securities Act. The typical size of these institutional private placement transactions generally range between $200 million and $600 million, and FBRC markets such transactions to QIBs and accredited investors and persons who are not “U.S. Persons” (as defined in Rule 902 under the Securities Act), all of whom have a pre-existing relationship with FBRC or the issuer of the securities.
On April 24, 2012, the Company completed the Private Offering that raised approximately $550 million in aggregate proceeds, and FBRC acted as initial purchaser and placement agent for the Private Offering.
FBRC's trading desk begins facilitating private trades among its customers following the closing of a private placement transaction. To give its customers additional transparency regarding these investments, FBRC operates an information site called FBRPlus, which is accessible through Bloomberg terminals. FBRPlus is accessible only to QIBs who have executed an access agreement with FBRC, and a related website hosted by FBRC called FBRPrivate, which is accessible only to accredited investors who are existing shareholders of the private issuer. The FBRPlus and FBRPrivate sites include information about the private issuer and its securities, such as historical private trading prices and volumes.
FBRC's independent research department will, under certain circumstances, initiate research coverage on a private issuer and produce research reports so that qualified buy-side accounts can benefit from the views of FBRC's research department. To ensure that these private research reports are not disseminated beyond qualified customers, FBRC posts the private reports to the FBRPlus and FBRPrivate sites in a view-only format that cannot be downloaded, printed or forwarded. Customers to whom FBRC has given access can only review the information on-screen while accessing the restricted sites. These procedures were followed in connection with the Communications.
The Company respectfully submits to the Staff that due to (1) the restricted distribution of the Communications, (2) the purpose of the Communications being to inform private investors, and (3) the fact that FBRC was not at the time of the Communications (and is not now) acting for any potential offerors in connection with any potential offerings under the Registration Statement, the Company does not believe that any of the Communications constitute communications or research reports of the type referred to in Comment 3.
However, if the Staff would like to review the Communications, the Company would propose to supplementally furnish the Staff with copies of the Communications on a confidential basis with the understanding that after the Staff has completed its review of the registration statement, it will return the Communications to the Company.
We note there is no public market for your shares of common stock, although you intend to seek quotation on the Over-the-Counter Bulletin Board. As such, please specify on the cover page and in the “Plan of Distribution” section, as appropriate, the price, or a bona fide range, at which the common shares will be offered to the public and indicate that once the securities are quoted on the OTCBB, they will be sold atRest of the question
prevailing market prices or at negotiated prices.
to the Staff's comment, the cover page of Amendment No. 1 and the “Plan of Distribution” section have been revised to clarify that there has not been a public market for our shares, and because all of the shares offered under the prospectus will be offered by the selling stockholders, we cannot currently determine the price or prices at which the shares may be sold under the prospectus.Read in the reply
Please include your company name on the cover page of the prospectus as required by Item 501(b)(1) of Regulation S-K.
to the Staff's comment, the cover page of the prospectus has been revised to include the Company name.Read in the reply
Please expand the discussion to indicate that as of March 31, 2013, you have not written any mortgage insurance.
to the Staff's comment, the Company has updated the Registration Statement to indicate that the Company commenced writing business in April 2013. The Company has provided the insurance-in-force, risk-in-force and premiums written through June 30, 2013 throughout Amendment No. 1. See, for example, pages 1, 54, 57, 63 and 68 of Amendment No. 1.Read in the reply
Please expand you summary of risk factors to include a brief description of the following risks: That you have a history losses and expect to continue to incur losses; and That you and certain of your officers are defendants in the PMI lawsuit, which if you are unsuccessful in defending, could prevent you from obtaining the remaining required licenses, subject you to significant monetary damages, or result inRest of the question
the removal of the officers involved.
to the Staff's comment, the Company has revised the summary of risk factors to include a description of the specified risks. Please refer to pages 4 and 5 of Amendment No. 1.Read in the reply
Please revise the second sentence of the heading of this risk factor to clarify that you have no operating history on which investors or you may rely for purposes of projecting your future operations.
to the Staff's comment, the company has revised the heading of this risk factor. Please refer to page 11 of Amendment No. 1.Read in the reply
Please revise this risk factor to clarify that, as you state on page 52, you have determined that IMS cannot effectively support your business needs. In addition, please expand this risk factor to describe the risk that, as you describe on page 99, your GSE Approval in conditioned on your having and maintaining a fully operational technology platform.
to the Staff's comment, the Company has revised the risk factor as requested. Please refer to page 13 of Amendment No. 1.Read in the reply
Please revise the heading and text of this risk factor to identify any additional risks of authorizing third-party lenders to bind insurance coverage on your behalf.
to the Staff's comment, the Company has revised the risk factor as requested. Please refer to page 15 of Amendment No. 1.Read in the reply
Please define “risk-in-force” the first time you use the term.
to the Staff's comment, the Company has defined “risk-in-force” the first time the term is used. Please refer to page 1 of Amendment No. 1.Read in the reply
Please revise the heading and text of this risk factor to clarify that you have reported net losses since inception. In addition, due to its potential significance to investors, please move this risk factor up to the beginning of this section after “We are a recently formed development stage corporation…”
to the Staff's comment, the Company has revised the risk factor as requested. Please refer to pages 11 - 12 of Amendment No. 1.Read in the reply
Please revise your disclosure to specify the approximate number of mortgage originators that dominate the mortgage market that makes up your potential customer base.
to the Staff's comment, the Company has revised its disclosure. Please refer to page 17 of Amendment No. 1.Read in the reply
Please expand this risk factor to describe the following risks: That your lack of operating history adds to the speculative nature of your loss estimates; and That you expect due the nature of your business that your losses will increase after the first two to three years of operations and that therefore your operating history will continue to be an unreliable indicator of future performance for at least theRest of the question
next few years.
to the Staff's comment, the Company has expanded the specified risk factor. Please refer to page 20 of Amendment No. 1.Read in the reply
Please expand this risk factor and revise the heading, as appropriate, to describe any other risks to your business posed by not being rated by a nationally recognized statistical rating organization, such as any impact on your ability to compete with other insurers who do have a rating.
to the Staff's comment, the Company has expanded the specified risk factor. Please refer to pages 21 - 22 of Amendment No. 1.Read in the reply
Please expand this risk factor to identify any key personnel other than your management team.
to the Staff's comment, the Company has expanded the specified risk factor. Please refer to page 22 of Amendment No. 1.Read in the reply
Please revise this risk factor to explain what you mean by “includes a target of $30 billion of unpaid principal balance in risk-sharing transactions.”
to the Staff's comment, the Company has expanded the specified risk factor. Please refer to pages 28 - 29 of Amendment No. 1.Read in the reply
Please combine this risk factor with or move it up to follow the risk factor on page 14 captioned “NMIC is required to maintain minimum capital…”
to the Staff's comment, the Company has moved the risk factor as requested. Please refer to page 16 of Amendment No. 1.Read in the reply
Please expand the discussion to state that: you have not declared or paid dividends in the past; you currently do not have earnings from which dividends may be paid; and currently only appreciation in the price of your common stock, which may never occur, will provide a return to investors.
to the Staff's comment, the Company has expanded its discussion regarding the payment of dividends. Please refer to page 34 of Amendment No. 1.Read in the reply
Please expand the discussion to provide a brief discussion of the development of MAC’s business including the extent of its mortgage insurance operations.
to the Staff's comment, the Company has expanded its discussion regarding the development of MAC's business. Please refer to pages 5 and 45 of Amendment No. 1.Read in the reply
Please revise the consolidated statements of operations and statements of cash flows for the Predecessor, shown on pages 8-9, 46-47 and 61-62, to cover the periods from January 1, 2012 to April 24, 2012 and July 6, 2009 (inception) to April 24, 2012 or tell us the basis for your presentation.
The Company respectfully advises the Staff that the basis of its presentation showing the period ending March 31, 2013 instead of April 24, 2012 was to present a period end consistent with the period end for the interim financial period ended March 31, 2013. The Company further advises the Staff that the activity that transpired from April 1, 2012 through April 24, 2012 was not meaningful. However, in response to the Staff's comment, the Company has included the period through April 24, 2012 in the Registration Statement. Please refer to pages 9 - 10, 48 - 49 and 66 - 67 of Amendment No.Read in the replyRest of the answer
1.
Management's Discussion and Analysis of Financial Condition and Results of Operations Factors Affecting Our Operating Results
Please expand your disclosure to explain why you withdrew your application for a certificate of authority in Florida and when and/or under what circumstances you expect to resubmit your application. In addition, please expand your disclosure to identify which remaining states require approval of your rates and/or policy forms before you may issue insurance policies in those states.
to the Staff's comment, the Company has revised its disclosure in the Registration Statement to indicate that it intends to refile its application for a certificate of authority in Florida by mid-August 2013. Please refer to pages 2, 13, 52 and 87 of Amendment No. 1. The Company respectfully advises the Staff that, as disclosed in the Registration Statement, the Company withdrew its initial application in Florida in response to a request from the FL OIR to do so.Read in the replyRest of the answer
The Company can only speculate at this time the basis on which the FL OIR requested withdrawal of the application; the FL OIR has not provided any documentation indicating the reasons for its request nor has it issued a formal denial of the application setting forth the grounds for denial. Therefore, the Company believes that it could be potentially misleading to investors to speculate on the basis for the FL OIR's request in the Registration Statement and believes that it has disclosed all material information regarding its application in Florida, including all material risks, to investors. The Registration Statement is clear that although the Company plans to resubmit its application, that the application may not ultimately be approved and that the Company may not be able to conduct business in Florida and that if the Company does not receive certificates of authority in all states, the volume of business the Company is able to write may be adversely affected. Please see pages 14 and 53 of Amendment No. 1.
Please expand your discussion of the PMI lawsuit on page 51 and the related risk factor on page 23 captioned “We, as well as certain of our officers, are party to a lawsuit…” to identify the officers other than your chief executive officer and chief financial officer that are parties to the lawsuit whom you may be required to remove and replace in the event of an adverse outcome in the litigation.
to the Staff's comment, the Company has expanded its discussion regarding the PMI lawsuit and the related risk factor. Please refer to pages 25 - 26 and 53 of Amendment No. 1.Read in the reply
Please expand your disclosure to specify the third party industry systems with which you believe you will need to connect and those with which you expect to be integrated by mid-2014.
to the Staff's comment, the Company has revised its disclosure regarding third party industry systems. Please refer to pages 54 - 55 of Amendment No. 1.Read in the reply
Please revise your disclosure to explain what you mean by “substantial progress within each of the segments” here and “significant progress in engaging these lenders” in the related risk factor captioned “Our inability to timely attract and retain the largest mortgage originators…” on page 14.
to the Staff's comment, the Company has revised its disclosure. Please refer to pages 16 and 56 of Amendment No. 1.Read in the reply
We note you have $150 thousand in risk-in-force as of May 31, 2013. Please expand the discussion to indicate the number of mortgage insurance policies this dollar amount represents.
to the Staff's comment, the Company has expanded its discussion to indicate the number of mortgage insurance policies $150,000 in risk-in-force represents. Please refer to page 57 of Amendment No. 1.Read in the reply
Please expand the discussion to indicate the basis for the estimated frequency of claims and severity of loss.
to the Staff's comment, the Company has expanded its discussion regarding the basis for the estimated frequency of claims and severity of loss. Please refer to page 59 of Amendment No. 1.Read in the reply
Please revise your disclosure here and on page 106 to explain what you mean by “Loans that are QM benefit from a statutory presumption from civil liability under the Dodd- Frank Act.”
to the Staff's comment, the Company has revised its disclosure. Please refer to pages 60, 61, 117 and 118 of Amendment No. 1.Read in the reply
Please revise your disclosure to define “Ginnie Mae.”
to the Staff's comment, the Company has revised its disclosure to define “Ginnie Mae.” Please refer to page 62 of Amendment No. 1.Read in the reply
Please revise your disclosure to explain what you mean by “leverage [your] fixed expenses" to improve you return on capital.
to the Staff's comment, the Company has revised its disclosure. Please refer to pages 63 and 64 of Amendment No. 1.Read in the reply
Expand your disclosure to state for each grant date, the number of options or shares granted, the exercise price, the fair value of the common stock, and the intrinsic value, if any, per option. Indicate how you determined the fair value of your common stock and whether the valuation used to determine the fair value of the common stock was contemporaneous or retrospective.
to the Staff's comment, the Company has expanded its disclosure regarding share-based compensation. Please refer to pages 75-78 of Amendment No. 1.Read in the reply
Please revise your disclosure to specify how many of the 60 sales employees you have hired to date and when you expect to be fully staffed.
to the Staff's comment, the Company has revised its disclosure regarding its sales employees. Please refer to page 95 of Amendment No. 1.Read in the reply
Please revise your disclosure to identify the third-party investment management company that managed your portfolio.
to the Staff's comment, the Company has revised its disclosure to identify the third party management company that managed its portfolio. Please refer to page 108 of Amendment No. 1.Read in the reply
Please revise the introductory paragraph or the footnotes to the table to identify the individual whose employment status changed and the nature of the change. In addition, please explain why the equity awards to Mr. McCourt were forfeited.
to the Staff's comment, the Company has revised its disclosure. Please refer to page 129 of Amendment No. 1.Read in the reply
Please disclose the flat dollar amount to be paid in lieu of perquisites to your named executive officers. Consolidated Financial Statements for the Period Ended March 31, 2013 Notes to Consolidated Financial Statements 9. Commitments and Contingencies, page F-16
to the Staff's comment, the Company has included an expanded discussion of perquisites in the Registration Statement. Please refer to page 133 of Amendment No. 1.Read in the reply
Consolidated Financial Statements for the Period Ended March 31, 2013
Notes to Consolidated Financial Statements
9. Commitments and Contingencies, page F-16
Please disclose the capitalization, operational and reporting conditions, imposed by Fannie Mar and Freddie Mac in connection with their approval of NMIC as a qualified mortgage insurer. 14. Statutory Financial Information, page F-20
to the Staff's comment, the Company has disclosed the capitalization, operational and reporting conditions imposed by Fannie Mae and Freddie Mac in connection with their respective approvals of NMIC as a qualified mortgage insurer. Please refer to pages F-16 and F-17 of Amendment No. 1.Read in the reply
14. Statutory Financial Information, page F-20
Please provide the following disclosure or tell us why your believe that this disclosure is not required: Disclose the amount of statutory capital and surplus necessary to satisfy regulatory requirements if significant in relation to the entity’s statutory capital and surplus, as required under ASC 944-505-50-1b. If not significant, clarify in the disclosure.Rest of the question
Disclose the amount of retained earnings that is restricted or free of restriction for payment of dividends to NMI Holdings, Inc. shareholders. Refer to Rule 4-08(e) (1) of Regulation S-X. Disclose the amounts of restricted net assets of subsidiaries as of December 31, 2012 or tell us how your current disclosure meets the objective of Rule 4-08(e) (3) of Regulation S-X.
to the Staff's comment, the Company has included additional disclosure regarding statutory financial information in the Registration Statement. Please refer to pages F-21 and F-22 of Amendment No. 1.Read in the reply
Please present net loss per share on the statements of operations for all periods presented for NMI Holdings, Inc. 14. Statutory Financial Information, page F-40
to the Staff's comment, the Company has included a disclosure of net loss per share for all periods presented in the Registration Statement. Please refer to page F-26 of Amendment No. 1.Read in the reply
14. Statutory Financial Information, page F-40
Please provide the following disclosure or tell us why your believe that this disclosure is
to the Staff's comment, the Company has included additional disclosure regarding statutory financial information in the Registration Statement. Please refer to the Company's response to Comment 37 and to pages F-41 and F-42 of Amendment No. 1.Read in the reply
Please file copies of the following agreements as exhibits pursuant to Item 601(b)(10) of Regulation S-K: Agreements with the GSEs reflecting the terms and conditions of your GSE Approval; Agreement with MAC Financial Ltd.Rest of the question
to acquire MAC; and Stock purchase agreements or form thereof from your April 2012 financing If you intend to respond to these comments with an amended draft registration statement, please submit it and any associated correspondence in accordance with the guidance we provide in the Division’s October 11, 2012 announcement on the SEC website at http://www.sec.gov/divisions/corpfin/cfannouncements/drsfilingprocedures101512.htm. Please keep in mind that we may publicly post filing review correspondence in accordance with our December 1, 2011 policy (http://www.sec.gov/divisions/corpfin/cfannouncements/edgarcorrespondence.htm). If you intend to use Rule 83 (17 CFR 200.83) to request confidential treatment of information in the correspondence you submit on EDGAR, please properly mark that information in each of your confidential submissions to us so we do not repeat or refer to that information in our comment letters to you.
to the Staff's comment, the Company has filed the agreements with the GSEs and the agreements with MAC Financial Ltd. as requested, which are included in the Registration Statement as Exhibits 2.1, 2.2, 99.1 and 99.2. The Company respectfully submits to the Staff that the Company does not have any ongoing obligations under the stock purchase agreements from its April 2012 financing and does not believe that these agreements are responsive to the exhibits required to be filed pursuant to Item 601 of Regulation S-K.Read in the replyRest of the answer
However, the Company is providing the form of stock purchase agreements supplementally under separate cover to the Staff on a confidential basis so that the Staff may review the agreements.
We note your response to our prior comment 4. However, Item 501(b)(3) of Regulation S-K requires a prospectus to include either a price or a description of the method used to calculate the price. “At the-market” offerings by selling stockholders do not satisfy this requirement unless and until there is an existing market for the securities.Rest of the question
Accordingly, please specify on the cover page and in the “Plan of Distribution” section, as appropriate, the price, or a bona fide range, at which the common shares will be offered to the public until such time as your securities are quoted on the OTCBB and describe the various factors considered in determining such offering price. Please refer to Item 501(b)(3) of Regulation S-K and the instructions thereto, as well as Item 505(a) of Regulation S-K.
The Company confirms its understanding of the Staff's comment and has specified on the cover page and in the "Plan of distribution" section, as appropriate, the bona fide range at which the Company's common stock will be offered to the public until such time as its securities are quoted on the OTC Bulletin Board (the "OTCBB"), and the Company has described the various factors considered in determining such offering price. Please refer to the Prospectus page and page 167 of Amendment No. 2.Read in the replyRest of the answer
The Company has provided for a range from $10.45 to $12.80, which is based on the bid/ask spread on September 6, 2013 for the Company's common stock reported on the FBR PLUSTM system, a proprietary trading platform developed by FBR Capital Markets Inc. that provides qualified institutional buyers (“QIBs”) access to trading information for companies that have issued restricted securities in private placement transactions exempt from registration pursuant to Rule 144A of the Securities Act of 1933, as amended. The reported trades represent arms-length transactions between non-affiliated QIBs which further strengthens the Company's reliance on these transactions to support its fair value calculations as discussed in the Company's response to Comment Nos. 2 and 3 below. Other factors the Company considered, which the Company believes are considered by the market participants and which are reflected in the price of the Company's common stock quoted on the FBR PLUSTM system, include the Company's operating and financial performance, current business conditions and projections and the market performance of comparable publicly traded companies.
Management's Discussion and Analysis of Financial Condition and Results of Operations Share Based Compensation, page 73
Please refer to prior comment 31. You determined the valuation of your common stock in accordance with the AICPA Practice Aid: Valuation of Privately-Held Company Equity Securities Issued as Compensation (“AICPA Practice Aid”), using the income and market-based approach. Also, you have relied upon observation of recent trading of your common stock within the FBR PLUS System.Rest of the question
However, your determination of fair value for grants from May 2012 through May 2013 appears to have been based principally on trading information from the FBR PLUS System. Please explain to us how you used the income and market-based approaches in these valuations. Also, explain the factors that you considered in concluding that your primary reliance on trading information from the FBR PLUS System was preferable to reliance on the income and market-based approaches prescribed in the AICPA Practice Aid. In addition, disclose the most significant methods and assumptions used in the contemporaneous valuation of your common stock as of February 14, 2013, as well as whether the valuations for each of your grants were contemporaneous or retrospective.
to the Staff's comment, the Company notes that in determining the fair value of the Company's common stock underlying the option and restricted stock unit ("RSU") grants from May 2012 through May 2013, the Company relied on recent reported trading of its common stock on the FBR PLUSTM System. The Company also considered numerous objective and subjective factors to determine the fair value of its common stock as of the date of each option and RSU grant.Read in the reply
There has been meaningful volume and frequency of trading activity of the Company's common stock reported on the FBR PLUSTM System, which theRest of the answer
Company believes supports its reliance on such activity when it determined the fair values of its option and RSU awards. As of the date of this letter, trades of approximately 10.1 million shares of the Company's common stock have been reported on the FBR PLUSTM System, with reported trades beginning in June 2012 and occurring monthly in 12 of the14 months since June 2012. Between May 2012 and receipt of GSE approvals in January 2013, observed reported trades on the FBR PLUSTM System were used to validate management's determination that the fair value of the Company's common stock had not changed from the April 24, 2012 offering price, as the Company was in its earliest development stages and had achieved no significant milestones.
In March 2013, the Company performed a retrospective valuation of the Company's common stock as of February 14, 2013 using a combination of two generally accepted approaches: the income approach using the discounted cash flow method, or DCF, and the market-based approach using the comparable company method. The Company also observed recent reported trading of the Company's common stock on the FBR PLUSTM System. The Company concluded the value of its common stock as of February 14, 2013, using the income and market-based approach, of $11.75 per share, fell within the price of reported trades observed on the FBR PLUSTM System on February 11, 2013 ($11.50 per share), February 21, 2013 ($11.90 per share) and February 22, 2013 ($12.00 per share). This valuation analysis confirmed the Company's belief that the trading activity reported on the FBR PLUSTM System provided a valid measure of the fair value of the Company's common stock and that greater reliance should be placed on these trades in determining fair value. The Company believes the extent of trading on the FBR PLUSTM System and the fact that the trades represent arms-length transactions between non-affiliated QIB's further strengthens its reliance on these transactions to support its fair value calculations.
As noted above, in order to determine the fair value of the Company's common stock underlying its option and RSU grants on February 14, 2013, the Company utilized a combination of the income approach, the market-based approach and observations of recent reported trading of its common stock on the FBR PLUSTM System. For the income approach, the Company utilized five year projections of net income, adjusted for depreciation and amortization, yearly capital expenditures and additions to working capital, to determine prospective future free cash flows and discounted the free cash flows using a discount rate based on its weighted average cost of capital. For the market approach, the Company estimated market value through analysis of recent prices of "guideline", or comparable, publicly traded companies. The Company compared various price/performance ratios of public companies who were also holding companies for mortgage insurance companies. In determining the fair value of the Company's common stock using the market approach, the Company applied a selected equity exit multiple to the last year of its five year projections of net income, adjusted as described above. The price to book multiple and price to earnings multiple applied were consistent with the multiples observed by the comparable companies prior to 2007, which is the point at which these companies experienced a rapid decline due to the financial crisis that is not indicative of current or anticipated future performance. The Company used multiples from prior to 2007 because the Company's primary operating subsidiary, NMIC, is a newly capitalized mortgage insurer that does not have the exposure to the losses experienced by many of its comparable companies during the recent financial crisis. The values determined by each of the discounted cash flow, comparable company method and recent observed reported trades of the Company's common stock on the FBR PLUSTM System were weighted, resulting in a fair value per share of common stock as of February 14, 2013 of $11.75. Estimates of the volatility of the Company's common stock were based on available information on the volatility of common stock of comparable publicly traded companies.
In response to the Staff's comment, the Company has disclosed the most significant methods and assumptions used in the valuation of its common stock as of February 14, 2013 and whether the valuations for each of its grants were contemporaneous or retrospective in "Management's Discussion and Analysis & Results of Operations - Results of Operations - Share Based Compensation". Please refer to pages 76 through 79 of Amendment No. 2.
Please progressively bridge management’s fair market value determinations to the current estimated IPO price range. Reconcile and explain the differences between the mid-point of your estimated offering price range and the fair values included in your analysis. Provide us with a chronology of events leading to the filing of your IPO.Rest of the question
If you do not have an estimated offering price in your next filing, we are deferring evaluation of stockbased compensation until your estimated offering price is specified. Continue to provide us with updates to the above analysis for all equity related transactions through the effectiveness date of the registration statement.
above, the Company has provided in Amendment No. 2 an estimated bona fide offering price range of $10.45 to $12.80, until such time as its common stock is quoted on the OTCBB. The factors the Company considered predominately include the price of reported trades in the Company's common stock trades on the FBR PLUSTM System, which trades represent arms-length transactions between non-affiliated QIB's.Read in the replyRest of the answer
The Company also considered other factors such as its operating and financial performance, current business conditions and projections and the market performance of comparable publicly traded companies.
The mid-point of the bona fide range is $11.63.
•
The Company determined that the fair value of its common stock from April 2012 through November 2012 was $10.00 per share.
◦
On April 24, 2012, the Company completed a private placement of 55,000,000 shares of its common stock for gross proceeds of $550 million or $10.00 per share. Concurrent with the close of its private placement, the Company granted stock options and RSUs that were valued at $10.00 per share. Between April 24, 2012 and May 30, 2012, there were no significant changes in the Company's business plan and the Company had just begun executing on its business strategy.
Between May 2012 and November 2012, the Company granted equity awards on May 30, 2012, November 7, 2012 and November 8, 2012. Between these same dates, the Company completed an organizational exam with the Wisconsin Office of the Commissioner of Insurance and became licensed to sell insurance in its state of domicile. The Company's strategy had not changed from the initial strategy detailed in the private placement memorandum issued to potential investors in connection with its April 2012 private placement offering; however, uncertainty remained as to the Company's ability to obtain
GSE approval by January 17, 2013. If the Company had not received GSE approval by January 17, 2013, the Company would have been required under the terms of the Company's agreement with existing shareholders to dissolve and distribute its remaining assets to its stockholders. In October 2012, the Company observed four reported trades of its common stock between $10.25 and $10.50, which indicated a possible increase in the fair value of the Company's stock as of October 30, November 7 and November 8, 2012; however, given the remaining uncertainty regarding the Company's GSE approvals and state licenses, the Company determined that the fair value of its common stock remained at the $10.00 per share private placement offering price. The difference between the mid-point of the range and the fair values of the October 30, November 7 and November 8, 2012 equity grants is $1.63, which the Company believes is attributable primarily to approval by the GSEs, securing state licenses in 48 states and the District of Columbia and commencing insurance operations, all of which occurred in 2013.
Between December 2012 and February 2013, the Company observed reported trading of approximately 1.8 million shares of the Company's common stock on the FBR PLUSTM System with trading prices between $10.50 and $12.00 per share. In January 2013, the Company's primary insurance subsidiary was approved by the GSEs as an eligible mortgage guaranty insurer. This event signaled future revenues for the Company and allowed net proceeds raised in the April 2012 private offering to be used for operating purposes. The Company granted additional stock options and RSUs on February 14, 2013. No trades occurred on February 14, 2013. Given the receipt of GSE approval, the Company performed a retrospective valuation of its common stock as of February 14, 2013 and determined the fair value of its common stock on that date was $11.75 per share. As discussed above in response to Comment No. 2, in order to determine the fair value of the Company's common stock as of February 14, 2013, the Company utilized a combination of two generally accepted approaches: the income approach using the discounted cash flow method, or DCF, and the market-based approach using the comparable company method, as well as observations of recent reported trading of the Company's common stock on the FBR PLUSTM System. Based on this valuation and the factors discussed above, the Company's Board of Directors granted stock options with an exercise price of $11.75 per share and RSUs with a fair value of $11.75 per share. There is no material difference between the mid-point of the range and the fair values of the February 14, 2013 grants largely because the Company had achieved the significant accomplishments mentioned above.
In March 2013, the Company observed trades of $13.00 and $13.50 on the same days that two of the Company's competitors, Radian and MGIC, announced the successful completion of debt and equity offerings of approximately $700 million and $1 billion, respectively. The price of the Company's common stock quoted on the FBR PLUSTM System experienced an increase that is likely attributable to these announcements, which the Company believes indicated renewed investor confidence in the private MI industry. During this time, the Company continued to pursue insurance licenses in all 50 states plus the District of Columbia and by mid-April 2013, the Company had received licenses in 47 states plus the District of Columbia. At this time, the Company believed the remaining 3 state licenses would be obtained imminently. In April 2013, the Company also announced the writing of its first insurance commitment; however, the Company did not observe any reported trades of its common stock on the FBR PLUSTM System in the month of April 2013. In April 2013, the Company began issuing policies on a pilot basis with a limited customer group. On May 9, 2013 and May 15, 2013, the Company granted stock options with exercise prices of $12.65 and $12.50, respectively. On May 14, 2013, a trade of the Company's common stock was reported on the FBR PLUSTM System at $12.50. Between May 15,
2013 and the initial filing of the Registration Statement on June 21, 2013, the Company received one additional state license but was also notified that the Company's application with Wyoming was not accepted, and in response to a request by the Florida Office of Insurance Regulation, the Company withdrew its application in Florida. During this same time period, the Company's premium revenue was lower than management had projected. The difference between the mid-point of the estimated offering price range of $11.63 and the fair values of the Company's common stock on May 9, 2013 and May 15, 2013 of $12.65 (a difference of ($1.02)) and $12.50 (a difference of ($.87)), respectively, reflects the uncertainty of obtaining licenses in Wyoming and Florida.
NMI Holdings, Inc. Consolidated Financial Statements for the Year Ended December 31, 2013 Statement of Operations, page F-26
The weighted average common shares of 55,500,100 for 2012 appears to be incorrect and should be 37,909,936 as stated on page 48. Please revise as necessary. 11. Stock Compensation, page F-38
to the Staff's comment, the Company has disclosed the correct weighted average common shares of 37,909,936, in the consolidated financial statements for the the year-ended December 31, 2012. Please refer to page F-26 of Amendment No. 2.Read in the reply
Disclose the weighted-average period over which the total compensation cost related to nonvested awards as of December 31, 2012 will be recognized in accordance with ASC 718-10-50-2i. Also disclose the weighted-average period for June 30, 2013.
to the Staff's comment, the Company has disclosed the the weighted-average period over which the total compensation cost related to nonvested awards as of December 31, 2012 will be recognized in accordance with ASC 718-10-50-2i. The Company has also disclosed the same for June 30, 2013. Please refer to pages F-19 and F-20 for the June 30, 2013 disclosure and F-39 and F-40 for the December 31, 2012 disclosure, of Amendment No. 2.Read in the reply
We note your revised disclosure in response to our prior comment 1 in which you state that you “expect the initial trading range to be between $10.45 and $12.80 per share” until a market develops for your stock. Please revise your disclosure here and elsewhere as appropriate to state specifically that until a market develops, the selling stockholders will sell any shares under the prospectus at such price range.
No reply letter found.
Please refer to prior comment 3. We are deferring a final evaluation of stock compensation until your estimated offering price is specified. Continue to provide us with updates to the analysis for all equity related transactions through the effectiveness date of the registration statement. We may have further comments in this regard, when the amendment containing this information is filed.
No reply letter found.
If you have no specific plans for the proceeds of this offering beyond working capital and other corporate purposes, please revise your disclosure to discuss the principal reasons for the offering pursuant to Item 504 of Regulation S-K.
No reply letter found.
We are deferring a final evaluation of stock compensation until your estimated offering price is specified. Continue to provide us with updates to the analysis for all equity related transactions through the effectiveness date of the registration statement. We may have further comments in this regard, when the amendment containing this information is filed.
No reply letter found.
Please file copies of the forms lock-up agreements entered into in connection with the private placement and this offering as exhibits to your registration statement pursuant to Item 601(b)(10) of Regulation S-K.
No reply letter found.